Unlocking the potential of K-RAS inhibitors

At AACR 2022 (8th–13th April) in New Orleans (LA, USA), we caught up with Kevan Shokat, Professor at the University of California, San Francisco (UCSF; CA, USA), and Investigator at Howard Hughes Medical Institute (MD, USA).  K-RAS was the first human oncogene discovered; however, for decades researchers struggled to find a binding pocket for inhibitors to bind to it. K-RAS was thought to be an undruggable oncogene, until finally in 2013, Kevan Shokat and his team made a discovery that opened the K-RAS-inhibitor floodgates. In this interview, we chat to Kevan about his prize-winning discovery and the bespoke technique that...